Featured Research

from universities, journals, and other organizations

Flu vaccine grown in bacteria works like vaccine grown in chicken eggs

Date:
December 7, 2010
Source:
University of Rochester Medical Center
Summary:
Only the fragile chicken egg stands between Americans and a flu pandemic that would claim tens of thousands more lives than are usually lost to the flu each year. Now scientists have taken an important step toward ending the dominance of the oval, showing that an experimental flu vaccine grown entirely in bacteria triggers in people an immune response that would protect them against the flu.

Only the fragile chicken egg stands between Americans and a flu pandemic that would claim tens of thousands more lives than are usually lost to the flu each year.

Related Articles


Vaccine production hinges on the availability of hundreds of millions of eggs -- and even with the vaccine, flu still claims somewhere around 36,000 lives in the United States during a typical year. Now scientists have taken an important step toward ending the dominance of the oval. In a paper published in the Dec. 6 issue of the journal Vaccine, scientists showed that an experimental flu vaccine grown entirely in bacteria -- a process that bypasses the egg completely -- works well in people, triggering an immune response that would protect them against the flu.

The study of 128 healthy people ages 18 to 49 at the University of Rochester Medical Center was led by John Treanor, M.D., an expert on flu vaccines who has helped lead efforts to create and test new ways to make flu vaccine more quickly and less expensively. The vaccine -- which is free of bacteria itself -- is made by New Jersey-based VaxInnate Inc., which funded the study.

"There are a number of problems with using eggs to produce flu vaccine," said Treanor. "It's a very specialized product. It's hard to make more eggs in a hurry -- you only get them as fast as hens lay them. They're not easy to manipulate, and it can be challenging to get the flu virus to grow within an egg. The flu vaccine system would be more flexible and reliable if we didn't have to rely on them."

Scientists have been exploring a number of alternatives to eggs -- creating doses to cover just the U.S. population requires millions of eggs that, if laid end to end, would just about encircle the continental United States.

Bacteria have not been high on the list of options, even though they have the capability of producing vaccine more quickly and less expensively than many other methods. Most efforts to use bacteria have faltered due to basic differences in the way that bacteria process proteins compared to more complex eukaryotic cells, which have a nucleus. Proteins are a crucial component of flu vaccine, and keeping the key proteins folded correctly has been a challenge in bacteria, which lack cellular machinery critical to the process.

"It was long accepted as dogma that you could not make a flu vaccine in bacteria that could stimulate a protective immune response in humans," said Treanor. "But in this vaccine, the surface flu protein hemagglutinin was made by E.coli in such a way that it folded correctly, stimulating an authentic immune response. It's almost surprising that this is possible."

VaxInnate addressed the problem by focusing on just one small key protein of hemagglutinin that can be correctly refolded after synthesis in bacteria. The small protein is enough to spur the immune system because it was attached to an adjuvant -- a compound designed to strengthen the vaccine by stimulating a more robust immune response. Adjuvants currently are not part of U.S. flu vaccines, though they are used in other countries and as parts of other vaccines. Usually, adjuvants are simply mixed into a vaccine, but the latest work offers a new method. A bacterial protein called flagellin was actually fused to a molecule that mimics the flu's hemagglutinin protein -- a combination designed both to draw the attention of the immune system and immediately amplify it in one step.

The amount of material in the experimental flu shot under study is just a fraction of the amount used in a licensed flu shot. The most successful tests were done with one or two micrograms of vaccine, much smaller than today's licensed 15-microgram shot. About half of participants got a strong immune response at 1 microgram, and about 80 percent got a strong immune response at 2 micrograms.

Also taking part in the study from the Medical Center were Christine Hay, M.D., assistant professor of Medicine; nurse practitioner Carrie Nolan; and technician Theresa Fitzgerald. Authors from VaxInnate included David Taylor, Lynda Tussey, Ge Liu, Uma Kavita, Langzhou Song, and Alan Shaw.


Story Source:

The above story is based on materials provided by University of Rochester Medical Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. John J. Treanor, David N. Taylor, Lynda Tussey, Christine Hay, Carrie Nolan, Theresa Fitzgerald, Ge Liu, Uma Kavita, Langzhou Song, Irving Dark. Safety and immunogenicity of a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125) in healthy young adults☆☆☆. Vaccine, 2010; DOI: 10.1016/j.vaccine.2010.10.009

Cite This Page:

University of Rochester Medical Center. "Flu vaccine grown in bacteria works like vaccine grown in chicken eggs." ScienceDaily. ScienceDaily, 7 December 2010. <www.sciencedaily.com/releases/2010/12/101206142654.htm>.
University of Rochester Medical Center. (2010, December 7). Flu vaccine grown in bacteria works like vaccine grown in chicken eggs. ScienceDaily. Retrieved October 24, 2014 from www.sciencedaily.com/releases/2010/12/101206142654.htm
University of Rochester Medical Center. "Flu vaccine grown in bacteria works like vaccine grown in chicken eggs." ScienceDaily. www.sciencedaily.com/releases/2010/12/101206142654.htm (accessed October 24, 2014).

Share This



More Health & Medicine News

Friday, October 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Breakfast Debate: To Eat Or Not To Eat?

Breakfast Debate: To Eat Or Not To Eat?

Newsy (Oct. 23, 2014) Conflicting studies published in the same week re-ignited the debate over whether we should be eating breakfast. Video provided by Newsy
Powered by NewsLook.com
Ebola Fears Keep Guinea Hospitals Empty

Ebola Fears Keep Guinea Hospitals Empty

AP (Oct. 23, 2014) Fears of Ebola are keeping doctors and patients alike away from hospitals in the West African nation of Guinea. (Oct. 23) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins